Hims & Hers Health (HIMS) Set to Announce Quarterly Earnings on Monday

Hims & Hers Health (NYSE:HIMS) is scheduled to be issuing its quarterly earnings data after the market closes on Monday, August 5th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Hims & Hers Health has set its FY 2024 guidance at EPS and its Q2 2024 guidance at EPS.Parties that are interested in participating in the company’s conference call can do so using this link.

Hims & Hers Health (NYSE:HIMS) last released its earnings results on Monday, May 6th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.02 by $0.03. The firm had revenue of $278.20 million during the quarter, compared to analysts’ expectations of $270.37 million. Hims & Hers Health had a negative net margin of 0.24% and a negative return on equity of 0.70%. The business’s quarterly revenue was up 45.8% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.05) EPS. On average, analysts expect Hims & Hers Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Hims & Hers Health Price Performance

NYSE:HIMS opened at $17.58 on Friday. The stock has a market cap of $3.78 billion, a P/E ratio of -1,758.00 and a beta of 1.08. Hims & Hers Health has a one year low of $5.65 and a one year high of $25.74. The company has a fifty day moving average price of $21.37 and a 200 day moving average price of $15.68.

Insider Transactions at Hims & Hers Health

In related news, CEO Andrew Dudum sold 188,888 shares of Hims & Hers Health stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $19.88, for a total transaction of $3,755,093.44. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Hims & Hers Health news, insider Patrick Harrison Carroll sold 10,000 shares of Hims & Hers Health stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $13.00, for a total value of $130,000.00. Following the transaction, the insider now owns 173,880 shares of the company’s stock, valued at $2,260,440. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Andrew Dudum sold 188,888 shares of Hims & Hers Health stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $19.88, for a total transaction of $3,755,093.44. The disclosure for this sale can be found here. Insiders sold a total of 782,901 shares of company stock worth $16,138,997 in the last quarter. 17.71% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages have issued reports on HIMS. Jefferies Financial Group boosted their price target on shares of Hims & Hers Health from $14.00 to $23.00 and gave the company a “hold” rating in a report on Thursday, June 27th. TD Cowen upped their target price on shares of Hims & Hers Health from $15.00 to $25.00 and gave the stock a “buy” rating in a report on Thursday, July 11th. Bank of America increased their price objective on shares of Hims & Hers Health from $22.00 to $26.00 and gave the stock a “buy” rating in a report on Thursday, June 13th. Citigroup lowered shares of Hims & Hers Health from a “buy” rating to a “neutral” rating and increased their price objective for the stock from $16.00 to $20.00 in a report on Wednesday, May 22nd. Finally, Seaport Res Ptn reissued a “buy” rating on shares of Hims & Hers Health in a report on Friday, April 26th. Seven investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $19.07.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.